Home > Signaling Pathways>Transmembrane>P-gp>Zosuquidar (RS 33295-198; LY335979) 3HCl
Zosuquidar (RS 33295-198; LY335979) 3HCl

This product is for research use only, not for human use. We do not sell to patients.

Zosuquidar (RS 33295-198; LY335979) 3HCl
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
250mg$710Check With Us
500mg$1250Check With Us
1g$1875Check With Us

Cat #: V1294 CAS #: 167465-36-3 Purity ≥ 98%

Description: Zosuquidar 3HCl (formerly D-06387; D06387; RS33295198; LY335979; LY-335979; RS-33295198), the trihydrochloride salt of zosuquidar, is a novel and potent inhibitor P-glycoprotein (P-gp) and modulator of P-gp-mediated multi-drug resistance with potential antitumor activity.

References: A H Dantzig, et al. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979. Cancer Res. 1996 Sep 15;56(18):4171-9.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)636.99
Molecular FormulaC32H31F2N3O2.3HCl
CAS No.167465-36-3
Storage-20℃ for 3 years in powder formr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 100 mg/mL (157 mM)r
Water: 23 mg/mL (36.1 mM)r
Ethanol:<1 mg/mL
Solubility In Vivo30% PEG400+0.5% Tween80+5% propylene glycol: 30 mg/mL
SynonymsRS 33295-198 (D06387) 3HCl; LY335979; D-06387; D 06387; RS33295198; LY 335979; LY-335979; RS 33295198; Zosuquidar HCl; Zosuquidar 3HCl; Zosuquidar trihydrochloride
ProtocolIn VitroZosuquidar (5-16 μM; 72 h) treatment alone shows high cytotoxic concentration to drug-sensitive and MDR cell lines
In VivoZosuquidar (intraperitoneal injection; 30 mg/kg; once daily; 5 d) treatment shows the potentiation with a combined of Doxorubicin
Animal modelMice implanted with P388/ADR tumors
Dosages30, 10, 3, or 1 mg/kg
AdministrationIntraperitoneal injection; 30, 10, 3, or 1 mg/kg; once daily; 5 days
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM1.5699 mL7.8494 mL15.6988 mL31.3977 mL
5mM0.3140 mL1.5699 mL3.1398 mL6.2795 mL
10mM0.1570 mL0.7849 mL1.5699 mL3.1398 mL
20mM0.0785 mL0.3925 mL0.7849 mL1.5699 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.